Who Paid My Doc
Atellica CH 930 Analyzer
Device DX - Diagnostics incl. all products and services
PDI 00630414002163
General payments
$92,454
Research payments
$2,420
Through program year 2025, $92,454 in general payments and $2,420 in research payments were reported against Atellica CH 930 Analyzer (DX - Diagnostics incl. all products and services).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $20,521 | 105 |
| 2024 | General | $43,170 | 125 |
| 2023 | General | $8,838 | 96 |
| 2022 | General | $17,298 | 52 |
| 2021 | General | $2,627 | 69 |
| 2021 | Research | $2,420 | 1 |
Breakdown
The top 5 of 83 recipients; each share is of general payments naming this product in 2025.
The top 5 of 34 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 26 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
447 general · 1 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.